{"gao_id": "GAO-18-646T", "published": "2018-07-11T12:00:00Z", "released": "2018-07-11T08:00:00Z", "summary": "To have their drugs covered under Medicaid, the \"340B\" program requires drug manufacturers to sell outpatient drugs to covered entities\u2014certain hospitals and clinics\u2014at a discount. These entities are increasingly contracting with pharmacies to dispense 340B drugs. Doing so can make it harder to ensure compliance with 340B rules. For example, contract pharmacies may also fill prescriptions for the general public, increasing the risk of dispensing...", "title": "Drug Discount Program: Improvements Needed in Federal Oversight of Compliance at 340B Contract Pharmacies", "topics": ["Discount rates", "Drug prices", "Outpatient care", "Prescription drugs", "Medicaid", "Patient care", "Health Care", "Health centers", "Medicaid program", "Health care centers", "Hospitals", "Drugs", "Pharmacy", "Insurance coverage", "Health care", "Medically uninsured"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-18-646t", "versions": [{"title": "Full Report (12 pages)", "url": "https://www.gao.gov/assets/gao-18-646t.pdf"}, {"title": "Accessible PDF (14 pages)", "url": "https://www.gao.gov/assets/700/694062.pdf"}]}